MP54-01 ASSOCIATION BETWEEN SOCIAL NEEDS AND PRIMARY TREATMENT CHOICE FOR LOCALIZED PROSTATE CANCER

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP54-01 ASSOCIATION BETWEEN SOCIAL NEEDS AND PRIMARY TREATMENT CHOICE FOR LOCALIZED PROSTATE CANCER Jay Rollins, Rutul D. Patel, Kevin Labagnara, and Kara L. Watts Jay RollinsJay Rollins More articles by this author , Rutul D. PatelRutul D. Patel More articles by this author , Kevin LabagnaraKevin Labagnara More articles by this author , and Kara L. WattsKara L. Watts More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003307.01AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Social Determinants of Health (SDH)–defined as the conditions where people are born, work, live, and age–impact patients’ access to resources and health outcomes in a variety of ways. Additionally, ethnic differences in primary treatment for prostate cancer have been demonstrated. We assessed the relationship between SDH score and primary treatment choice for localized prostate cancer in a diverse, urban patient population. METHODS: Using our institutional registry, we conducted a retrospective study of men diagnosed with prostate cancer between 2003–2022. Primary treatment choice–defined as either radiation therapy (RT) or radical prostatectomy (RP)–was abstracted with clinical variables. A validated SDH questionnaire, distributed over the past 5 years by our institution’s primary care department, provided self-reported demographics and patients’ concerns regarding specific social risks. Multivariable analyses controlling for age, PSA, and Gleason grade group at diagnosis were performed to analyze the association between SDH variables and primary treatment choice for localized prostate cancer. RESULTS: 217 patients completed the SDH questionnaire and met inclusion criteria; 118 (54%) and 99 (46%) received primary RT and RP, respectively. Median age was 64 years. The cohort was primarily non-Hispanic Black (43%) or Hispanic (41%), English-speaking (80%), and insured through Medicare (65%). Table 1 reports the results of binomial logistic regression models assessing the relationship between the variables of interest and primary treatment selection. Compared to White patients, patients of all other races/ethnicities were more likely to undergo prostatectomy (Non-Hispanic Black OR=9.54, p=0.04; Hispanic OR=9.55, p=0.04; Asian/Other OR=13.87, p=0.03). No specific SDH concern endorsed by patients was significantly associated with treatment choice (p>0.05 for all). CONCLUSIONS: Analysis of our cohort indicates that unmet social needs do not influence primary treatment selection for localized prostate cancer. This suggests the presence of other variables that contribute to racial/ethnic differences in treatment choice. Future studies are needed to investigate the social and cultural factors that influence how patients determine primary treatment for localized prostate cancer. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e753 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jay Rollins More articles by this author Rutul D. Patel More articles by this author Kevin Labagnara More articles by this author Kara L. Watts More articles by this author Expand All Advertisement PDF downloadLoading ...